Quick Answer
Zymeworks Inc. reported Earnings Per Share Diluted of $1.08 (loss) per share for the year ending 2025.
- Zymeworks Inc. showed an increase of +33.3% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from Zymeworks Inc.'s annual report (Form 10-K), filed with the SEC on March 2, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2021: $1.25 (loss) per share | Q1 2022: $1.19 (loss) per share | Q2 2022: $0.97 (loss) per share | Q3 2022: $0.72 (loss) per share | Q1 2023: $0.37 (loss) per share | Q2 2023: $0.76 (loss) per share | Q3 2023: $0.41 (loss) per share | Q1 2024: $0.42 (loss) per share | Q2 2024: $0.49 (loss) per share | Q3 2024: $0.39 (loss) per share | Q1 2025: $0.30 (loss) per share | Q2 2025: $0.03 per share | Q3 2025: $0.26 (loss) per share.
- Over the full 6 years of available data (2020 to 2025), Zymeworks Inc.'s Earnings Per Share Diluted has grown by 69.8%.
- Historical annual values: Fiscal year 2025: $1.08 (loss) per share | Fiscal year 2024: $1.62 (loss) per share | Fiscal year 2023: $1.72 (loss) per share | Fiscal year 2022: $1.90 per share | Fiscal year 2021: $4.61 (loss) per share | Fiscal year 2020: $3.58 (loss) per share.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: